ARCHIVES

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

This article is from The Cancer Letter archive.

Vol. 15 No. 16 | April 21, 1989

Download PDF Visit The Full Archive

Related Articles

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

ASCO Supports CT Scans For Colorectal Screening

November 25, 2005

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

July 11, 2003

Major League Baseball Begins Struggle to Eject Ever-Present Smokeless Tobacco Forom The Sport

April 12, 1991

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

December 13, 1996

List of 100 Highest-Paid NIH Officials

February 12, 2010